Want to Save Lives? Detect Oral Cancer EARLY!

Want to Save Lives? Detect Oral Cancer EARLY! March 24, 2015 Did you know that early diagnosis of oral cancer can more than double a patient’s chances of survival?  What if a simple oral rinse could help determine if your patients are at risk for oral cancer?  We could save countless lives with such a

Developer of Oral Cancer Testing System Motivated by Parents’ Disease

Developer of Oral Cancer Testing System Motivated by Parents’ Disease March 24, 2015 They say necessity is the mother of invention. But for Matthew H.J. Kim, founder and CEO of Vigilant Biosciences, the motivation for developing the OncAlert oral cancer detection system was seeing the ordeal his parents went through with the disease. The system

Vigilant Biosciences Debuts OncAlert Oral Cancer Risk Assessment System at IDS 2015

Vigilant Biosciences Debuts OncAlert Oral Cancer Risk Assessment System at IDS 2015 March 13, 2015 Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, debuted its OncAlert Oral Cancer Risk Assessment System in Hall 4.2 Booth #N049 at the International Dental Show (IDS) 2015, the

Vigilant Biosciences Announces Agreement with Biotech-IgG AB for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Scandinavia

Vigilant Biosciences Announces Agreement with Biotech-IgG AB for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Scandinavia March 11, 2015 COLOGNE, Germany Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive

An Awesome Day: Vigilant Biosciences’ New $30 Oral Cancer Screening System Gets $5-Million Backing

An Awesome Day: Vigilant Biosciences’ New $30 Oral Cancer Screening System Gets $5-Million Backing March 11, 2015 Yesterday, Vigilant Biosciences introduced the world to its OncAlert Oral Cancer Risk Assessment System, the company’s revolutionary oral cancer screening and identification product. To top things off, it also announced $5 million in guaranteed purchases in a five-year

Vigilant Biosciences Enters Agreement with BL&H Co., Ltd. for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Korea

Vigilant Biosciences Enters Agreement with BL&H Co., Ltd. for Exclusive Distribution of the OncAlert™ Oral Cancer Product Line in Korea March 10, 2015 COLOGNE, Germany Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a five-year

Oral Rinse May Detect Early-Stage Cancer

Oral Rinse May Detect Early-Stage Cancer March 9, 2015 The OncAlert oral cancer risk assessment system from Vigilant Biosciences Inc, Miami, is based on patented technology and designed to detect specific protein markers known to indicate an elevated risk for oral cancer, even before symptoms are observed. Noninvasive and easy to administer, the procedure requires

Vigilant Biosciences to Exhibit and Present at International Dental Show 2015

Vigilant Biosciences to Exhibit and Present at International Dental Show 2015 March 6, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it will debut its OncAlert™ Oral Cancer product line in Hall 4.2 Booth #N049 at

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev C